An Exploration of More Sustainable Methods of Pharmaceutical Research & Production
Paras Biopharmaceutical is a SME CDMO company operating in northern Finland. This report was commissioned in order to ascertain if their sustainability efforts reflect current industry standards, alongside identifying possible avenues to increase them. The research focuses on three sections: waste m...
Main Author: | |
---|---|
Format: | Other/Unknown Material |
Language: | English |
Published: |
2022
|
Subjects: | |
Online Access: | http://www.theseus.fi/handle/10024/748344 |
id |
fttheseus:oai:www.theseus.fi:10024/748344 |
---|---|
record_format |
openpolar |
spelling |
fttheseus:oai:www.theseus.fi:10024/748344 2023-05-15T17:42:45+02:00 An Exploration of More Sustainable Methods of Pharmaceutical Research & Production Coates, Timothy 2022 http://www.theseus.fi/handle/10024/748344 eng eng Paras Biopharmaceuticals http://www.theseus.fi/handle/10024/748344 URN:NBN:fi:amk-202205149246 CC BY 4.0 Rajattu käyttöoikeus / Restricted access / Tillgången är begränsad CC-BY fi=Liiketalous hallinto ja markkinointi|sv=Företagsekonomi förvaltning och marknadsföring|en=Business Management Administration and Marketing| sustainable development pharmaceutical industry waste management business wastes recycling logistics Degree Programme in International Business fi=AMK-opinnäytetyö|sv=YH-examensarbete|en=Bachelor's thesis| 2022 fttheseus 2022-05-18T23:02:50Z Paras Biopharmaceutical is a SME CDMO company operating in northern Finland. This report was commissioned in order to ascertain if their sustainability efforts reflect current industry standards, alongside identifying possible avenues to increase them. The research focuses on three sections: waste management, single-use items and logistics, as these were identified as key areas for the business to evaluate and possibly improve upon. The study first establishes Paras Biopharmaceuticals current approach before examining why and how a business should engage with sustainability and environmentalism. The pharmaceutical industries relationship with sustainability is then evaluated, before assess Finland’s national approach, and complimentary industries that the commissioner may partner with. Following this, the primary research of this work collects data from interviews and reports provided by a varied selection of pharmaceutical companies reflecting both large multinational organizations and Finnish start-ups. The data clearly demonstrating interest and focus on sustainability as an industry concern. Waste management was found to be focused on minimalizing recycling and reducing landfill, carbon emissions and water usage. For single-use items the results showed only one innervation for laboratory waste, while the broader trend revealed replacements for consumer products and product packaging. Evaluating logistics brought into focus the efforts all logistic providers make in accounting for their impact on the environment. In concluding, this work finds that Paras Biopharmaceuticals efforts are reflective of their peers: other pharmaceutical SME of equal size offer comparable sustainability effort. Should Paras Biopharmaceuticals wish to increase their sustainability efforts they are best pursued via reduction of landfill, carbon emissions and water usage. Other/Unknown Material Northern Finland Theseus.fi (Open Repository of the Universities of Applied Sciences) Paras ENVELOPE(20.139,20.139,69.111,69.111) |
institution |
Open Polar |
collection |
Theseus.fi (Open Repository of the Universities of Applied Sciences) |
op_collection_id |
fttheseus |
language |
English |
topic |
fi=Liiketalous hallinto ja markkinointi|sv=Företagsekonomi förvaltning och marknadsföring|en=Business Management Administration and Marketing| sustainable development pharmaceutical industry waste management business wastes recycling logistics Degree Programme in International Business |
spellingShingle |
fi=Liiketalous hallinto ja markkinointi|sv=Företagsekonomi förvaltning och marknadsföring|en=Business Management Administration and Marketing| sustainable development pharmaceutical industry waste management business wastes recycling logistics Degree Programme in International Business Coates, Timothy An Exploration of More Sustainable Methods of Pharmaceutical Research & Production |
topic_facet |
fi=Liiketalous hallinto ja markkinointi|sv=Företagsekonomi förvaltning och marknadsföring|en=Business Management Administration and Marketing| sustainable development pharmaceutical industry waste management business wastes recycling logistics Degree Programme in International Business |
description |
Paras Biopharmaceutical is a SME CDMO company operating in northern Finland. This report was commissioned in order to ascertain if their sustainability efforts reflect current industry standards, alongside identifying possible avenues to increase them. The research focuses on three sections: waste management, single-use items and logistics, as these were identified as key areas for the business to evaluate and possibly improve upon. The study first establishes Paras Biopharmaceuticals current approach before examining why and how a business should engage with sustainability and environmentalism. The pharmaceutical industries relationship with sustainability is then evaluated, before assess Finland’s national approach, and complimentary industries that the commissioner may partner with. Following this, the primary research of this work collects data from interviews and reports provided by a varied selection of pharmaceutical companies reflecting both large multinational organizations and Finnish start-ups. The data clearly demonstrating interest and focus on sustainability as an industry concern. Waste management was found to be focused on minimalizing recycling and reducing landfill, carbon emissions and water usage. For single-use items the results showed only one innervation for laboratory waste, while the broader trend revealed replacements for consumer products and product packaging. Evaluating logistics brought into focus the efforts all logistic providers make in accounting for their impact on the environment. In concluding, this work finds that Paras Biopharmaceuticals efforts are reflective of their peers: other pharmaceutical SME of equal size offer comparable sustainability effort. Should Paras Biopharmaceuticals wish to increase their sustainability efforts they are best pursued via reduction of landfill, carbon emissions and water usage. |
format |
Other/Unknown Material |
author |
Coates, Timothy |
author_facet |
Coates, Timothy |
author_sort |
Coates, Timothy |
title |
An Exploration of More Sustainable Methods of Pharmaceutical Research & Production |
title_short |
An Exploration of More Sustainable Methods of Pharmaceutical Research & Production |
title_full |
An Exploration of More Sustainable Methods of Pharmaceutical Research & Production |
title_fullStr |
An Exploration of More Sustainable Methods of Pharmaceutical Research & Production |
title_full_unstemmed |
An Exploration of More Sustainable Methods of Pharmaceutical Research & Production |
title_sort |
exploration of more sustainable methods of pharmaceutical research & production |
publishDate |
2022 |
url |
http://www.theseus.fi/handle/10024/748344 |
long_lat |
ENVELOPE(20.139,20.139,69.111,69.111) |
geographic |
Paras |
geographic_facet |
Paras |
genre |
Northern Finland |
genre_facet |
Northern Finland |
op_relation |
Paras Biopharmaceuticals http://www.theseus.fi/handle/10024/748344 URN:NBN:fi:amk-202205149246 |
op_rights |
CC BY 4.0 Rajattu käyttöoikeus / Restricted access / Tillgången är begränsad |
op_rightsnorm |
CC-BY |
_version_ |
1766144665766068224 |